National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$96.75
add to cart

Rights & Permissions

topleft topright

Adverse Effects of Pertussis and Rubella Vaccines (1991)
Institute of Medicine (IOM)

Citation Manager

. "Appendix B: Pertussis and Rubella Vaccines: A Brief Chronology." Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC: The National Academies Press, 1991.

Please select a format:

BibTeX EndNote RefMan


Page
331
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Page 331

Kendrick P. 1942. Use of alum-treated pertussis vaccine, and of alum-precipitated combined pertussis vaccine and diphtheria toxoid, for active immunization. American Journal of Public Health 32:615-626.

Kendrick P. 1943. A field study of alum-precipitated combined pertussis vaccine and diphtheria toxoid for active immunization. American Journal of Hygiene 38:193-202.

Kendrick P, Eldering G. 1936. Progress report on pertussis immunization. American Journal of Public Health 26:8-12.

Kendrick P, Eldering G. 1939. A study in active immunization against pertussis. American Journal of Hygiene 29:133-153.

Kilroy AW, Schaffner W, Fleet WF, Lefkowitz LB, Karzon DT, Fenichel GM. 1970. Two syndromes following rubella immunization: clinical observations and epidemiological studies. Journal of the American Medical Association 214:2287-2292.

Koplan JP, Hinman AH. 1987. Decision analysis, public policy, and pertussis: are they compatible? Medical Decision Making 7:72-73.

Kulenkampff M, Schwartzman JS, Wilson J. 1974. Neurological complications of pertussis inoculation. Archives of Disease in Childhood 49:46-49.

Lerman SJ, Nankervis GA, Heggie AJ, Gold E. 1971. Immunologic response, virus excretion and joint reactions with rubella vaccine: a study of adolescent girls and young women given live attenuated virus vaccine (HPV-77:DE-5). Annals of Internal Medicine 74:67-73.

Madsen T. 1925. Whooping cough: its bacteriology, diagnosis, prevention, and treatment. Boston Medical and Surgical Journal 192:50-60.

Madsen T. 1933. Vaccination against whooping cough. Journal of the American Medical Association 101:187-188.

Manclark CR, ed. 1990a. Sixth International Symposium on Pertussis, Abstracts. DHHS Publication No. (FDA) 90-1162. Bethesda, MD: Public Health Service, U.S. Department of Health and Human Services.

Manclark CR, ed. 1990b. Proceedings of the Sixth International Symposium on Pertussis. DHHS Publication No. (FDA) 90-1164. Bethesda, MD: Public Health Service, U.S. Department of Health and Human Services.

Marcuse EK, Wentz KR. 1990. The NCES reconsidered: summary of a 1989 workshop. Vaccine 8:531-535.

Menkes JH, Kinsbourne M. 1990. Workshop on neurologic complications of pertussis and pertussis vaccination. Neuropediatrics 21:171-176.

Osler J. 1988. Judgment in Rothwell vs. Raes, Hall, and Connaught Laboratories. Supreme Court of Ontario, November 18, 1988. Toronto.

Plotkin SA. 1988. Rubella vaccine. In: Plotkin SA, Mortimer EA, Jr., eds. Vaccines. Philadelphia: W.B. Saunders Co.

Pollock TM, Morris J. 1983. A 7-year survey of disorders attributed to vaccination in North West Thames region. Lancet 1:753-757.

Rowlands DF, Freestone DS. 1971. Vaccination against rubella of susceptible schoolgirls in Reading. Journal of Hygiene 69:579-586.

Sauer L. 1933a. Whooping cough: a study in immunization. Journal of the American Medical Association 101:239-241.

Sauer L. 1933b. Immunization with bacillus pertussis vaccine. Journal of the American Medical Association 101:1449-1451.

Schaffner W, Fleet WF, Kilroy AW, Lefkowitz LB, Herrmann KL, Thompson J, Karzon DT. 1974. Polyneuropathy following rubella immunization: a follow-up study and review of the problem. American Journal of Diseases of Children 127:684-688.

Spruance SL, Smith CB. 1971. Joint complications associated with derivatives of HPV-77 rubella virus vaccine. American Journal of Diseases of Children 122:105-111.

Page
331